Signpath Pharma Competitors and Similar CompaniesClear all
Signpath Pharma's competitors and similar companies include Nektar Therapeutics and Exelixis.
 Signpath Pharma SignPath Pharma is a biotechnology company that develops products to treat cancer and mitigate drug-induced cardiac arrhythmia. | |||
Founding Date | Founding Date 2006 | Founding Date 1990 | Founding Date 1994 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Sandy, US HQ | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations Alameda, US HQ |
Employees | Employees 11 | Employees 61821% increase | Employees 1,14712% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 233.8 m | Valuation ($) 8.2 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $55.2m (FY, 2025) | Revenue (est.) $2.3b (FY, 2025) |
Net income | Net income N/A | Net income ($164.1m) (FY, 2025) | Net income $782.6m (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 5.3m | Total funding raised $ 45m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Nektar Therapeutics
HQ
San Francisco, US
Employees
618↑ 21% increase
Nektar Therapeutics is a stage-clinical biopharmaceutical company.
View company
Exelixis
HQ
Alameda, US
Employees
1,147↓ 12% decrease
Exelixis is an oncology company that develops cancer treatments.
View company